Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome. (17/63)

 (+info)

Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. (18/63)

 (+info)

Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. (19/63)

 (+info)

Over-nutrition and metabolic cardiomyopathy. (20/63)

 (+info)

Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure. (21/63)

 (+info)

Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency. (22/63)

 (+info)

Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease. (23/63)

 (+info)

Cardio-renal-anemia syndrome: a report of three cases. (24/63)

Patients with chronic kidney diseases (CKDs) and cardiovascular diseases (CVDs) present with various degree of anemia. Anemia has been associated with poor outcome in patients with CKD and CVD. CVD is the commonest cause of morbidity and mortality in patients with CKD. CKD causes anemia and CVD, and this rapidly deteriorates when anemia is not corrected. This triad of CVD, CKD, and anemia has been termed cardio-renal-anemia syndrome. The objective of this study is to highlight the importance of cardio-renal-anemia syndrome, their relationship, and management. Three patients with various stages of CKD who presented with anemia and cardiovascular abnormalities are reported. The patients responded well to various interventional measures, with improvement in their clinical and laboratory parameters. Cardio-renal-anemia syndrome is an entity that should be identified. Early and appropriate intervention leads to better outcome.  (+info)